Thursday, April 3, 2014

Hobby Lobby's Hypocrisy: The Company's Retirement Plan Invests in Contraception Manufacturers | Mother Jones

If you don't like to ACA just say it.  Don't find a reason today, when it wasn't a reason before.
Hobby Lobby's Hypocrisy: The Company's Retirement Plan Invests in Contraception Manufacturers | Mother Jones:

These companies include Teva Pharmaceutical Industries, which makes Plan B and ParaGard, a copper IUD, and Actavis, which makes a generic version of Plan B and distributes Ella. Other holdings in the mutual funds selected by Hobby Lobby include Pfizer, the maker ofCytotec and Prostin E2, which are used to induce abortions; Bayer, which manufactures the hormonal IUDs Skyla andMirena; AstraZeneca, which has an Indian subsidiary that manufactures Prostodin, Cerviprime, and Partocin, three drugs commonly used in abortions; and Forest Laboratories, which makes Cervidil, a drug used to induce abortions. Several funds in the Hobby Lobby retirement plan also invested in Aetna and Humana, two health insurance companies that cover surgical abortions, abortion drugs, and emergency contraception in many of the health care policies they sell.
In a brief filed with the Supreme Court, the Greens object to covering Plan B, Ella, and IUDs because they claim that these products can prevent a fertilized egg from implanting in a woman's uterus—a process the Greens consider abortion. But researchers reject the notionthat emergency contraceptive pills prevent implantation the implantation of a fertilized egg. Instead, they work by delaying ovulation or making it harder for sperm to swim to the egg. (Copper IUDs, which are also a form of birth control, can prevent implantation.) The Green's contention that the pills cause abortions is a central pillar of their argument for gutting the contraception mandate. Yet, for years, Hobby Lobby's health insurance plans did cover Plan B and Ella. It was only in 2012, when the Greens considered filing a lawsuit against the Affordable Care Act, that they dropped these drugs from the plan.
'via Blog this'

No comments: